Related Experiment Videos

[Marfan syndrome]

Guillaume Jondeau1, Gabriel Delorme, Chabnam Guiti

  • 1Consultation multidisciplinaire Marfan et service de cardiologie Hôpital Ambroise Paré 92100 Boulogne. guillaume.jondeau@apr.ap-hop-paris.fr

La Revue Du Praticien
|July 11, 2002
PubMed

Insights

Marfan syndrome, a genetic disorder affecting fibrillin-1, requires early diagnosis through aortic screening and examinations. Management includes lifestyle changes, medication, and regular monitoring to prevent aortic dissection.

Area of Science:

  • Genetics
  • Cardiology
  • Rheumatology
  • Ophthalmology

Context:

  • Marfan syndrome is an autosomal dominant genetic disorder.
  • It is associated with abnormalities in fibrillin-1.
  • Diagnosis can be challenging, often requiring a high index of suspicion.

Purpose:

  • To highlight the diagnostic challenges of Marfan syndrome.
  • To emphasize the importance of early detection and screening for aortic aneurysms.
  • To outline management strategies for Marfan syndrome patients.

Summary:

  • Marfan syndrome diagnosis involves recognizing non-atheromatous ascending aortic aneurysms and performing family screening.
  • Extracardiac signs should be evaluated through ophthalmological and rheumatological examinations.
  • Management focuses on preventing aortic complications through lifestyle modifications, beta-blockers, and regular aortic diameter monitoring.

Impact:

  • Early diagnosis and intervention can prevent life-threatening aortic dissection.
  • Regular monitoring allows for timely surgical repair of the ascending aorta.
  • Comprehensive evaluation ensures management of systemic manifestations.

Related Concept Videos